CaliPharms, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KGET research report →
Price Chart
About the company
CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis industry across the United States. The company's primary focus lies within the THC and CBD-infused beverage sector.
- CEO
- Eric Watson
- IPO
- 2013
- Employees
- 4
- HQ
- Temecula, CA, US
Get TickerSpark's AI analysis on KGET
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $474.35K
- P/E
- -0.40
- PEG
- -0.00
- P/S
- 39.53
- P/B
- -0.11
- EV/EBITDA
- -0.62
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -11222.67%
- Net Margin
- -11861.40%
- ROE
- 19.88%
- ROIC
- 37.43%
Latest fiscal year · YoY change
- Revenue
- $12.00K+0.0%
- Gross Profit
- $12.00K+0.0%
- Op Income
- $-1,346,720
- Net Income
- $-1,423,368-222.3%
- EPS
- $-0.00+0.0%
- OCF Growth
- -1445.3%
- FCF Growth
- -1445.3%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 5.30
- RSI (14)
- 53
- Avg Volume
- 459.79K
No earnings-call transcripts are available for KGET yet.
- Free Float
- 100.0%
- Shares Outstanding
- 11.86B
- Float Shares
- 11.86B
Our KGET coverage
Recent articles, reports, and earnings notes.
No research on KGET yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KGET report →